...a handful of Japanese and U.S. pharmas: Taiho Pharmaceutical Co. Ltd., Sumitomo...

...than linear RNAs and immune cell therapies. MPM Capital, which seeded and incubated the start-up, and Taiho...
...and Dan AndersonAcademic collaborators: MITCorporate partners: N/ANumber of employees: 25Funds raised: over $100 millionInvestors: MPM Capital, Taiho...

...to the company. The PDUFA date is in August.Taiho’s pimitespib meets in GIST studyPimitespib (TAS-116) from Taiho Pharmaceutical Co. Ltd....
...due to critical COVID-19 if trends seen at 28 days read through to 60 days. BC Staff Taiho Pharmaceutical Co. Ltd. Pfizer...

...Ingelheim GmbH and Taiho Pharmaceutical Co. Ltd. each have partnerships with MD Anderson that involve the TRACTION platform; Taiho’s...

...distribution rights in India.Taiho breaks ground in EuropeTaiho Pharmaceutical Co. Ltd. opened a new headquarters, Taiho...
...Peanut (DBV-712) Ultomiris, ravulizumab-cwvz (ALXN1210) Darzalex Faspro, DARA-PH20, subcutaneous daratumumab DBV Technologies S.A. Thermo Fisher Scientific Groupe Novasep S.A.S. Alexion Pharmaceuticals Inc. Taiho Pharmaceutical Co. Ltd....

...pivotal trial for recurrent H3 K27M-mutant glioma. A confirmatory response rate evaluation is expected this year. Epidarex, Taiho...
...Taiho Ventures, with participation from existing investor Oxford Sciences Innovation (OSI).  Epidarex’s Henning Steinhagen and Taiho...

...Sphera Healthcare and CaaS Capital. Returning investors from its $56 million series A are Longwood Fund, Taiho...

...A round led by SR One and Taiho...

...similar efficacy through a better therapeutic window. The EGFR inhibitor, which was spun out from Taiho...
...non-small cell lung cancer (NSCLC) study, which the company hopes to complete by year-end (see “Taiho’s...
...Epidermal growth factor receptor FLT3 (CD135) - FMS-like tyrosine kinase 3 ligand Lauren Martz, Senior Editor Taiho...

...Taiho Ventures is using a recently upsized fund to find cutting edge modalities that take Taiho...
...a prime example of how Taiho Ventures operates as both the corporate venture arm of Taiho Pharmaceutical Co. Ltd....
...Area biotech (see “Arcus Keeps its Independence” ) In a deal facilitated by Taiho Ventures, Taiho...